Alkem Laboratories · NSE: ALKEM · BSE: 539523
Q2 FY20 results · Jul–Sep 2019
Alkem Laboratories reported revenue from operations of ₹2,264.03 crore (up 18.0% from Q2 FY19) and net profit of ₹380.52 crore (up 46.1% from Q2 FY19) for Q2 FY20 (Jul–Sep 2019), on a consolidated basis.
| Item | Q2 FY20 | Q2 FY19 | YoY | Q1 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 2,264.03 | 1,918.92 | +18.0% | 1,849.50 | +22.4% |
| Other income | 31.42 | 24.02 | +30.8% | 17.47 | +79.9% |
| Total income | 2,295.45 | 1,942.94 | +18.1% | 1,866.97 | +23.0% |
| Profit before tax | 409.86 | 326.02 | +25.7% | 210.02 | +95.2% |
| Net profit for the period | 380.52 | 260.42 | +46.1% | 187.29 | +103.2% |
| Attributable to shareholders of the company | 370.85 | 254.47 | +45.7% | 185.47 | +100.0% |
| EPS, basic (₹) | 31.02 | 21.28 | +45.7% | 15.51 | +100.0% |
| Net margin (%) | 16.8 | 13.6 | 10.1 |
| Item | Q2 FY20 | Q2 FY19 | YoY | Q1 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,894.65 | 1,440.22 | +31.6% | 1,498.51 | +26.4% |
| Other income | 30.59 | 23.43 | +30.6% | 12.72 | +140.4% |
| Total income | 1,925.24 | 1,463.65 | +31.5% | 1,511.23 | +27.4% |
| Profit before tax | 465.29 | 284.77 | +63.4% | 228.56 | +103.6% |
| Net profit for the period | 434.02 | 238.30 | +82.1% | 210.62 | +106.1% |
| EPS, basic (₹) | 36.30 | 19.93 | +82.1% | 17.62 | +106.1% |
| Net margin (%) | 22.9 | 16.5 | 14.1 |
Consolidated
- Filed with BSE
- 11 Nov 2019, 18:23 IST
- Board meeting
- 11 Nov 2019
- Period
- 01 Jul 2019 to 30 Sep 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 11 Nov 2019, 18:23 IST
- Board meeting
- 11 Nov 2019
- Period
- 01 Jul 2019 to 30 Sep 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE